Stay updated on Lenva+Pembro Combo in Cancers: Clinical Trial
Sign up to get notified when there's something new on the Lenva+Pembro Combo in Cancers: Clinical Trial page.

Latest updates to the Lenva+Pembro Combo in Cancers: Clinical Trial page
- Check3 days agoChange DetectedAdded a 'Gastric cancer' entry in the resources section, referencing the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check10 days agoChange DetectedAdded Revision: v3.4.2; removed the site-wide government-funding lapse notice and the prior Revision: v3.4.1 notice.SummaryDifference0.4%

- Check17 days agoChange DetectedAdded a government funding lapse notice at the top of the page to inform users about potential data currency issues, and updated the site version to v3.4.1 while removing the previous revision note v3.4.0.SummaryDifference0.4%

- Check24 days agoChange DetectedUI text updates add the glossary label and capitalization changes (Last Update Submitted that Met QC Criteria, No FEAR Act Data) along with a new Revision: v3.4.0 label replacing the previous v3.3.4.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page now displays Revision: v3.3.4; the previous Revision: v3.3.3 has been removed.SummaryDifference0.1%

- Check59 days agoChange DetectedTokyo is added as a study location in the Locations section and the page revision is updated to v3.3.3. The HHS Vulnerability Disclosure and Tokyo Locations references are removed.SummaryDifference0.2%

Stay in the know with updates to Lenva+Pembro Combo in Cancers: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenva+Pembro Combo in Cancers: Clinical Trial page.